Sumitomo Mitsui Trust Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $95.7M | Buy |
293,542
+2,066
| +0.7% | +$674K | 0.06% | 303 |
|
2025
Q1 | $78.7M | Buy |
291,476
+4,773
| +2% | +$1.29M | 0.06% | 332 |
|
2024
Q4 | $67.5M | Buy |
286,703
+8,462
| +3% | +$1.99M | 0.05% | 376 |
|
2024
Q3 | $76.5M | Buy |
278,241
+1,294
| +0.5% | +$356K | 0.05% | 345 |
|
2024
Q2 | $67.3M | Sell |
276,947
-14,049
| -5% | -$3.41M | 0.05% | 359 |
|
2024
Q1 | $43.5M | Sell |
290,996
-4,283
| -1% | -$640K | 0.03% | 531 |
|
2023
Q4 | $56.5M | Sell |
295,279
-1,421
| -0.5% | -$272K | 0.04% | 438 |
|
2023
Q3 | $52.5M | Sell |
296,700
-1,929
| -0.6% | -$342K | 0.04% | 432 |
|
2023
Q2 | $56.7M | Sell |
298,629
-42,338
| -12% | -$8.04M | 0.04% | 433 |
|
2023
Q1 | $68.3M | Buy |
340,967
+3,991
| +1% | +$799K | 0.05% | 396 |
|
2022
Q4 | $80.1M | Sell |
336,976
-1,709
| -0.5% | -$406K | 0.06% | 354 |
|
2022
Q3 | $67.8M | Buy |
338,685
+843
| +0.2% | +$169K | 0.06% | 388 |
|
2022
Q2 | $49.3M | Buy |
337,842
+15,099
| +5% | +$2.2M | 0.04% | 513 |
|
2022
Q1 | $52.7M | Sell |
322,743
-1,709
| -0.5% | -$279K | 0.04% | 518 |
|
2021
Q4 | $55M | Sell |
324,452
-8,119
| -2% | -$1.38M | 0.03% | 516 |
|
2021
Q3 | $62.8M | Sell |
332,571
-15,344
| -4% | -$2.9M | 0.04% | 472 |
|
2021
Q2 | $59M | Sell |
347,915
-22,469
| -6% | -$3.81M | 0.03% | 502 |
|
2021
Q1 | $52.3M | Sell |
370,384
-11,027
| -3% | -$1.56M | 0.03% | 530 |
|
2020
Q4 | $49.6M | Sell |
381,411
-61,284
| -14% | -$7.97M | 0.03% | 537 |
|
2020
Q3 | $64.5M | Sell |
442,695
-116,349
| -21% | -$16.9M | 0.04% | 424 |
|
2020
Q2 | $82.8M | Sell |
559,044
-170,925
| -23% | -$25.3M | 0.06% | 354 |
|
2020
Q1 | $79.5M | Buy |
729,969
+286,933
| +65% | +$31.2M | 0.07% | 318 |
|
2019
Q4 | $51M | Buy |
443,036
+8,603
| +2% | +$991K | 0.04% | 477 |
|
2019
Q3 | $34.9M | Buy |
434,433
+86,454
| +25% | +$6.95M | 0.03% | 545 |
|
2019
Q2 | $25.2M | Sell |
347,979
-3,034
| -0.9% | -$220K | 0.02% | 616 |
|
2019
Q1 | $32.8M | Buy |
351,013
+31,459
| +10% | +$2.94M | 0.03% | 544 |
|
2018
Q4 | $22.5M | Buy |
319,554
+52,110
| +19% | +$3.67M | 0.02% | 583 |
|
2018
Q3 | $23.4M | Sell |
267,444
-3,851
| -1% | -$337K | 0.03% | 588 |
|
2018
Q2 | $26.7M | Buy |
271,295
+16,110
| +6% | +$1.59M | 0.03% | 551 |
|
2018
Q1 | $30.4M | Buy |
255,185
+15,369
| +6% | +$1.83M | 0.04% | 490 |
|
2017
Q4 | $30.5M | Buy |
+239,816
| New | +$30.5M | 0.04% | 490 |
|
2016
Q4 | – | Sell |
-210,934
| Closed | -$14.3M | – | 886 |
|
2016
Q3 | $14.3M | Buy |
210,934
+11,580
| +6% | +$785K | 0.02% | 603 |
|
2016
Q2 | $11.1M | Sell |
199,354
-10,255
| -5% | -$569K | 0.02% | 619 |
|
2016
Q1 | $13.2M | Buy |
209,609
+7,824
| +4% | +$491K | 0.02% | 604 |
|
2015
Q4 | $19.1M | Buy |
201,785
+4,865
| +2% | +$460K | 0.03% | 531 |
|
2015
Q3 | $15.8M | Buy |
196,920
+2,804
| +1% | +$225K | 0.03% | 569 |
|
2015
Q2 | $23.3M | Buy |
+194,116
| New | +$23.3M | 0.04% | 488 |
|